Axsome Therapeutics (AXSM) Q1 2023 Earnings Call Transcript

AXSM earnings call for the period ending March 31, 2023.

Related Keywords

United States ,America ,Marc Goodman ,Mark Jacobson ,Myles Minter William Blair ,Vikram Purohit ,Piper Sandler ,Joe Thome Cowen ,Charles Duncan ,Myles Minter ,Yatin Suneja Guggenheim ,Vikram Purohit Morgan Stanley ,William Blair ,Graig Suvannavejh ,Joseph Thome ,Sunosi Europe ,Jason Gerberry ,David Amsellem ,Ram Selvaraju ,David Amsellem Piper Sandler ,Herriot Tabuteau ,Nick Pizzie ,Yatin Suneja ,Joon Lee ,Matt Kaplan ,Lori Englebert ,Joon Lee Truist ,Matt Kaplan Ladenburg Thalmann ,Graig Suvannavejh Mizuho ,Charles Duncan Cantor Fitzgerald ,International Sunosi ,Company Analyst ,Pfizer ,Cantor Fitzgerald ,Exchange Commission ,Morgan Stanley ,Ladenburg Thalmann ,Business Development ,Axsome Therapeutics ,Motley Fool Stock Advisor ,Stock Advisor ,Axsome Therapeutic ,Middle East ,North Africa ,Hercules Capital ,Vice President ,Disease Agitation ,Truist Securities ,Guggenheim Partners ,